Maruo Calcium Co., Ltd. AI Stock Analysis
Want to see JP:4102 full AI Analyst Report?
Maruo Calcium Co., Ltd. (4102) AI Stock Analysis
Maruo Calcium Co., Ltd.
(TSE/TYO:4102)
The overall score of 62.5 is primarily driven by a solid financial foundation and attractive valuation. The company's strong balance sheet and significantly improved cash flow generation are key strengths. A low P/E ratio of 8.5 and a high dividend yield of 4.17% further enhance the investment case. However, these positives are tempered by a neutral technical outlook and underlying operational challenges, including sluggish revenue and thin operating margins.
Maruo Calcium Co., Ltd. (4102) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 3.07B
- Dividend Yield
- 4.17%
- Average Volume (3M)
- 659
- Price to Earnings (P/E)
- 8.5
- Beta (1Y)
- 0.13
- Revenue Growth
- 8.59%
- EPS Growth
- 119.18%
- Country
- Japan
- Employees
- 239
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals
Maruo Calcium Co., Ltd. Business Overview & Revenue Model
Company Description
Maruo Calcium Co., Ltd., a Japan-based firm, specializes in the manufacturing and sale of diverse calcium carbonate products and various other industrial raw materials. Its comprehensive product line includes multiple forms of calcium carbonate, such...
Maruo Calcium Co., Ltd. Financial Statement Overview
Summary
Financial performance is mixed but improving. The balance sheet is strong with low leverage (D/E 0.24) and a solid equity base. Cash flow has rebounded significantly, with operating cash flow exceeding net income and free cash flow turning positive. However, revenue is slightly declining and operating margins remain thin, capping the score.
Income Statement
58NeutralBalance Sheet
70PositiveCash Flow
68Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.05B | 12.64B | 12.84B | 12.89B | 12.59B | 11.57B |
| Gross Profit | 2.29B | 2.19B | 2.12B | 2.24B | 2.27B | 2.11B |
| EBITDA | 726.58M | 671.13M | 524.47M | 632.42M | 515.25M | 725.98M |
| Net Income | 359.33M | 293.51M | 148.63M | 249.24M | 117.14M | 190.80M |
Balance Sheet | ||||||
| Total Assets | 17.07B | 17.13B | 16.87B | 17.01B | 16.99B | 15.64B |
| Cash, Cash Equivalents and Short-Term Investments | 2.50B | 2.65B | 2.39B | 3.15B | 3.65B | 3.26B |
| Total Debt | 2.27B | 2.42B | 2.31B | 2.04B | 2.66B | 1.99B |
| Total Liabilities | 6.56B | 6.84B | 6.66B | 7.02B | 7.29B | 6.34B |
| Stockholders Equity | 10.31B | 10.08B | 9.80B | 9.62B | 9.30B | 8.90B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 414.29M | -617.93M | 207.05M | -225.65M | 203.10M |
| Operating Cash Flow | 0 | 959.18M | 246.92M | 508.99M | 464.80M | 529.34M |
| Investing Cash Flow | 0 | -650.52M | -1.17B | -345.73M | -745.35M | -441.94M |
| Financing Cash Flow | 0 | -62.26M | 116.41M | -762.08M | 606.48M | -478.57M |
Maruo Calcium Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4102, the sentiment is Negative. The current price of 1442.00 is below the 20-day moving average (MA) of 1448.55, below the 50-day MA of 1448.18, and above the 200-day MA of 1434.00, indicating a neutral trend. The MACD of -0.10 indicates Positive momentum. The RSI at 47.71 is Neutral, neither overbought nor oversold. The STOCH value of 50.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4102.
Maruo Calcium Co., Ltd. Peers Comparison
Overall Rating
JP:815871Outperform
JP:404067Neutral
JP:409366Neutral
JP:410262.5Neutral
JP:496054Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 71Outperform | JPY 31.32B | 12.74 | ― | 3.36% | 6.03% | 25.63% | |
| 67Neutral | JPY 8.94B | 2.44 | ― | 1.69% | -0.40% | 215.27% | |
| 66Neutral | JPY 14.02B | 10.45 | ― | 3.49% | 2.52% | 20.63% | |
| 63Neutral | JPY 3.22B | 8.51 | ― | 4.17% | 8.59% | 119.18% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 54Neutral | JPY 7.40B | 19.35 | ― | 1.11% | 6.87% | 300.65% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4102 | Maruo Calcium Co., Ltd. | 1442.00 | 69.54 | 5.07% | |
| JP:4040 | NANKAI CHEMICAL COMPANY LIMITED | 3760.00 | 813.55 | 27.61% | |
| JP:4093 | Toho Acetylene Co., Ltd. | 402.00 | 60.91 | 17.86% | |
| JP:4960 | Chemipro Kasei Kaisya,Ltd. | 456.00 | 138.39 | 43.57% | |
| JP:8158 | Soda Nikka Co., Ltd. | 1450.00 | 474.76 | 48.68% |
Maruo Calcium Co., Ltd. Corporate Events
Maruo Calcium Reports Higher First-Half Sales and Profit
Maruo Calcium Co. reported consolidated net sales of ¥6,857 million for the six months ended September 30, 2026, up 13.7% year on year. Operating profit was ¥56 million, versus a ¥21 million operating loss a year earlier, while ordinary profit rose 6...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 17, 2026
